Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polysomnography Study of Gabapentin Enacarbil in RLS
NCT00748098Phase 3Completed
- Sponsor
- XenoPort, Inc.
- Start
- Oct 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gabapentin enacarbil in restless legs syndrome (RLS), sponsored by XenoPort, Inc.. Started Oct 2008; status: completed.
02
Drugs
gabapentin enacarbil
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00748098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00748098.